Completion of Transaction

RNS Number : 1433O
Circassia Group Plc
28 May 2020
 

28 May 2020

Circassia Group plc

Completion of Transaction

Circassia Group plc ("Circassia" or "the Company") announces that the proposed transfer of the Tudorza and Duaklir assets to AstraZeneca first announced on 9 April 2020 has now completed.

 

Ian Johnson, Executive Chairman of Circassia, said:  "The completion of this transaction transforms Circassia into a debt-free business.  Niox® is a highly differentiated respiratory diagnostic platform that will be able to deliver long-term growth and enhanced shareholder returns."

 

-Ends-

For further information, please contact:

Circassia Group plc

 

Ian Johnson, Executive Chairman

 

 

c/o Peel Hunt

Michael Roller, CFO




Peel Hunt (Nominated Adviser and Joint Broker)

Tel: +44 (0) 20 7418 8900

James Steel / Oliver Jackson




finnCap (Joint Broker)

Tel: +44 (0) 20 7220 0500

Geoff Nash / Alice Lane




Numis Securities (Joint Broker)

Tel: +44 (0) 20 7260 1000

James Black / Duncan Monteith


 

 

 

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DISFFFEIEVIDFII

Companies

Niox Group (NIOX)
UK 100

Latest directors dealings